Plans typically require prior authorization to demonstrate medical necessity, and some plans require patients to engage in diet and exercise and/or enrollment in formal behavioral modification programs in order to obtain coverage
GSTP1 methylation has a strong influence on liver-related diseases and may play a role in the treatment of liver-related diseases
However, Medicare Part D still does not cover medications prescribed solely for weight loss, even for FDA-approved weight management agents, due to statutory exclusions under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
With the right tools, education, and accountability, long-term weight loss is absolutely possible
This concept is crucial when thinking about how often you need to inject a medication to keep it working effectively
Previous real-world evidence studies have shown dulaglutide to be associated with greater treatment persistence and adherence compared with semaglutide QW, liraglutide, and exenatide QW [26,27,28,29]